Nicholas D Schiff Selected Research

Persistent Vegetative State (Vegetative State)

1/2019	Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.
1/2019	Daytime Central Thalamic Deep Brain Stimulation Modulates Sleep Dynamics in the Severely Injured Brain: Mechanistic Insights and a Novel Framework for Alpha-Delta Sleep Generation.
1/2016	Late and progressive alterations of sleep dynamics following central thalamic deep brain stimulation (CT-DBS) in chronic minimally conscious state.
1/2013	Central thalamic deep brain stimulation for support of forebrain arousal regulation in the minimally conscious state.
7/2012	Central thalamic deep brain stimulation to promote recovery from chronic posttraumatic minimally conscious state: challenges and opportunities.
10/2010	Central thalamic deep brain stimulation for cognitive neuromodulation - a review of proposed mechanisms and investigational studies.
1/2010	Conflicts of interest in deep brain stimulation research and the ethics of transparency.
10/2009	A Bayesian statistical analysis of behavioral facilitation associated with deep brain stimulation.
6/2009	Deep brain stimulation, neuroethics, and the minimally conscious state: moving beyond proof of principle.
12/2006	How should functional imaging of patients with disorders of consciousness contribute to their clinical rehabilitation needs?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas D Schiff Research Topics

Disease

10	Persistent Vegetative State (Vegetative State) 01/2019 - 12/2006
7	Brain Injuries (Brain Injury) 01/2022 - 12/2007
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 07/2012
6	Coma (Comas) 01/2021 - 10/2010
6	Consciousness Disorders 01/2021 - 12/2006
3	Heart Arrest (Cardiac Arrest) 03/2019 - 01/2016
2	Epilepsy (Aura) 01/2022 - 01/2017
2	COVID-19 01/2022 - 01/2020
2	Seizures (Absence Seizure) 01/2017 - 01/2015
1	Pain (Aches) 01/2022
1	Critical Illness (Critically Ill) 01/2021
1	Mental Fatigue 01/2021
1	Delirium 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Shock 01/2020
1	Death (Near-Death Experience) 01/2017
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2016
1	Blindness (Hysterical Blindness) 01/2016
1	Paralysis (Palsy) 01/2016
1	Disorders of Excessive Somnolence (Hypersomnia) 04/2014
1	Chronic Brain Injury 09/2011
1	Parkinson Disease (Parkinson's Disease) 10/2009
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 10/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2008

Drug/Important Bio-Agent (IBA)

3	Amantadine (Aman)FDA LinkGeneric 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 10/2016 - 02/2012
2	Zolpidem (Ambien)FDA LinkGeneric 11/2013 - 09/2011
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Biological ProductsIBA 03/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2019
1	Apomorphine FDA Link 01/2019
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 08/2008

Therapy/Procedure

12	Deep Brain Stimulation 01/2022 - 12/2007
5	Therapeutics 01/2022 - 10/2009
3	Anesthesia 01/2021 - 12/2014
3	Induced Hypothermia 03/2019 - 01/2016
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2020
2	Neurological Rehabilitation 12/2011 - 12/2006
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Home Nursing (Nursing, Home) 04/2014
1	General Anesthesia 12/2010